science pharmaceutical expo biotech jobs

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moors, M. A.
Right arrow Articles by Mizel, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moors, M. A.
Right arrow Articles by Mizel, S. B.
(Journal of Leukocyte Biology. 2000;68:131-136.)
© 2000 by Society for Leukocyte Biology

Proteasome-mediated regulation of interleukin-1ß turnover and export in human monocytes

Marlena A. Moors and Steven B. Mizel

Department of Microbiology and Immunology, Wake Forest University Medical Center, Winston-Salem, North Carolina

Correspondence: Steven Mizel, Dept. of Microbiology and Immunology, Wake Forest University Medical Center, Winston-Salem, NC 27157. E-mail: smizel{at}wfubmc.edu

Interleukin-1ß is a secreted protein that accumulates in the cytosol as an inactive precursor (pIL-1ß) before processing and release of biologically active protein. To understand the impact of this property on IL-1ß production, we examined the intracellular stability of pIL-1ß in lipopolysaccharide (LPS)-stimulated human monocytes. Precursor IL-1ß was degraded with a relatively short half-life of 2.5 h in the promonocytic cell line, THP-1, and in primary monocytes. MG132 (carbobenzoxyl-leucinyl-leucinyl-leucinal) stabilized pIL-1ß levels in THP-1 cells, suggesting that degradation was proteasome-mediated, but this inhibitor was toxic for primary monocytes, causing release of pIL-1ß as well as the cytoplasmic enzyme, lactate dehydrogenase (LDH) into supernatants. In contrast, clasto-lactacystin ß-lactone, a specific inhibitor of the proteasome, caused a dose-dependent stabilization of intracellular pIL-1ß, and this led to a corresponding increase in mIL-1ß and pIL-1ß but not LDH release into culture supernatants. Therefore, by regulating intracellular levels of precursor IL-1ß, the proteasome plays an important and previously unrecognized role in controlling the amount of biologically active IL-1ß that is exported by activated monocytes.

Key Words: THP-1 • MG132 • lactacystin • precursor interleukin-1ß • degradation




This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
J. Hernandez-Rodriguez, M. Segarra, C. Vilardell, M. Sanchez, A. Garcia-Martinez, M. J. Esteban, C. Queralt, J. M. Grau, A. Urbano-Marquez, A. Palacin, et al.
Tissue production of pro-inflammatory cytokines (IL-1{beta}, TNF{alpha} and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis
Rheumatology, March 1, 2004; 43(3): 294 - 301.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Qureshi, P.-Y. Perera, J. Shen, G. Zhang, A. Lenschat, G. Splitter, D. C. Morrison, and S. N. Vogel
The Proteasome as a Lipopolysaccharide-Binding Protein in Macrophages: Differential Effects of Proteasome Inhibition on Lipopolysaccharide-Induced Signaling Events
J. Immunol., August 1, 2003; 171(3): 1515 - 1525.
[Abstract] [Full Text] [PDF]